Stockreport

Barinthus Bio Reports Third Quarter 2025 Financial Results and Updates on Corporate Developments

Barinthus Biotherapeutics plc - American Depositary Shares  (BRNS) 
PDF Single ascending dose data readout for VTP-1000 expected before the end of 2025Enrollment advancing in multiple ascending dose part of the AVALON trial; data expected in [Read more]